ArticleScientific reports2022

Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a.

Riki Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.